Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Calcipotriol Plus Hydrocortisone Ointment on the Hypothalamic-pituitary-adrenal (HPA) Axis and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and on the Intertriginous Areas

NCT00704262 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT00704262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00704262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Calcipotriol Plus Hydrocortisone Ointment on the Hypothalamic-pituitary-adrenal (HPA) Axis and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and on the Intertriginous Areas
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2008
Completion date
December 31, 2009
Enrollment
33 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris